Active Ingredient History

NOW
  • Now
Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy. It was designed by PTC Therapeutics.   Wikipedia

  • SMILES: OC(=O)c1cccc(c1)c2noc(n2)c3ccccc3F
  • InChIKey: OOUGLTULBSNHNF-UHFFFAOYSA-N
  • Mol. Mass: 284.25
  • ALogP: 3.24
  • ChEMBL Molecule:
More Chemistry
3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid | ataluren | ec-000.2051 | ptc124 | ptc 124 | ptc-124 | translarna

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue